CHILDRENS MAPAP ACETAMINOPHEN
-
acetaminophen liquid
Major
Drug Facts
Acetaminophen 160 mg
Fever reducer-Pain reliever
Temporarily relieves minor aches and pains due to:
Temporarily reduces fever
This product contains acetaminophen. Severe liver damage may occur if your child takes:
If sore throat is severe, persists for more than 2 days, is accompanied or followed by fever, headache, rash, nausea, or vomiting, consult a doctor promptly.
Ask a doctor before use if your child has liver disease
Ask a doctor or pharmacist before use if your child is taking the blood thinning drug warfarin.
Stop use and ask a doctor if
These could be signs of a serious condition.
If pregnant or breast-feeding, ask a health professional before use
Keep out of the reach of children.
Taking more than the recommended dose (overdose) may cause liver damage. In case of overdose, get medical help or contact a Poison Control Center (1-800-222-1222) right away. Quick medical attention is critical for adults as well as children even if you do not notice any signs or symptoms.
Weight | Age | Dose |
---|---|---|
under 24 lbs | Under 2 years | ask a doctor |
24 to 35 lbs | 2 to 3 years | 1 TSP (5 mL) |
36 to 47 lbs | 4 to 5 years | 1 1/2 TSP (7.5 mL) |
48 to 59 lbs | 6 to 8 years | 2 TSP (10 mL) |
60 to 71 lbs | 9 to 10 years | 2 1/2 TSP (12.5 mL) |
72 to 95 lbs | 11 years | 3 TSP (15 mL) |
artificial flavor, citric acid anhydrous, D&C Red #33, FD&C Red #40, glycerin, polyethylene glycol 1450, propylene glycol, purified water, sodium benzoate, sodium saccharin,sorbitol
To Report Adverse Drug Event call 1-800-616-2471 Weekdays, 9AM - 5PM Eastern Time
NDC 0904-1985-20
TAMPER EVIDENT
MAJOR®
Children's
FEVER REDUCER-PAIN RELIEVER
Māpap®
ACETAMINOPHEN LIQUID
Fast, Effective Relief
of Children's
Fever and Pain
See New Warnings Information
COMPARE TO the active
ingredient of TYLENOL®* LIQUID
4 Fl. OZ. (118mL)
80 mg per 1/2 teaspoonful (160 mg per 5 mL)
CHILDRENS MAPAP ACETAMINOPHEN
acetaminophen liquid | ||||||||||||||||||||||||||
| ||||||||||||||||||||||||||
| ||||||||||||||||||||||||||
| ||||||||||||||||||||||||||
| ||||||||||||||||||||||||||
|
Marketing Information | |||
Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date |
OTC MONOGRAPH FINAL | part343 | 08/20/2012 |
Labeler - Major (191427277) |